Pre-exposure prophylaxis (PrEP) and COVID-19: independent advisory group report
A report on using neutralising monoclonal antibodies (nMABs) in a prophylaxis setting for patients with highest-risk of hospitalisation or death from COVID-19.
A report on using neutralising monoclonal antibodies (nMABs) in a prophylaxis setting for patients with highest-risk of hospitalisation or death from COVID-19.